ACTR1B: A Potential Drug Target and Biomarker (G10120)

Target Name: ACTR1B

NCBI ID: G10120

ACTR1B

ACTR1B: A Potential Drug Target and Biomarker

Actinin-associated protein 1B (ACTR1B) is a protein that is expressed in various tissues and organs, including the brain, pancreas, and heart. It is a member of the actinin family, which includes proteins that play a critical role in cytoskeletal organization and regulation of cell signaling pathways. Several studies have identified potential drug targets and biomarkers associated with ACTR1B, making it an attractive candidate for further research and development.

Potential Drug Targets

Actinin-associated protein 1B is a protein that is involved in a wide range of cellular processes, including cytoskeletal organization, cell signaling pathways, and cell survival. Several studies have identified potential drug targets associated with ACTR1B. These targets include:

1. Microtubules: ACTR1B is a key protein that is involved in the organization and regulation of microtubules, which are dynamic structures that play a critical role in cell signaling pathways. Microtubules are made up of a protein called tau, which is involved in the formation and stability of the microtubules. Studies have shown that ACTR1B is involved in the regulation of microtubule stability and dynamics, and that changes in microtubule stability contribute to the pathophysiology of various diseases, including cancer.
2. Cell signaling pathways: ACTR1B is involved in a wide range of signaling pathways, including the regulation of cell proliferation, differentiation, and survival. It is a key protein that is involved in the signaling pathway known as the TGF-β pathway, which is involved in the regulation of cell growth and differentiation. Studies have shown that changes in the TGF-β pathway can contribute to the development and progression of various diseases, including cancer.
3. Cell survival: ACTR1B is involved in the regulation of cell survival, including the regulation of cell apoptosis. Apoptosis is a natural process that is involved in the regulation of cell life and death, and it is a critical mechanism that helps to remove damaged or dysfunctional cells from the body. Studies have shown that changes in the regulation of cell apoptosis can contribute to the development and progression of various diseases, including cancer.

Biomarkers

Actinin-associated protein 1B (ACTR1B) is also a potential biomarker for several diseases, including cancer. The ability of ACTR1B to serve as a biomarker makes it an attractive candidate for the development of new diagnostic tools and therapies.

1. Liquid biopsy: Liquid biopsy is a technique that involves the collection of small samples of cancer cells from the tumor and the use of these samples to develop diagnostic tests. Studies have shown that ACTR1B is expressed in a wide range of cancer cell types, including those from breast, lung, and ovarian cancers. The use of ACTR1B as a biomarker for cancer has the potential to improve the accuracy and sensitivity of diagnostic tests and to identify new targets for cancer therapies.
2. Biomarker research in cancer: ACTR1B is a potential biomarker for several types of cancer, including breast, lung, and ovarian cancers. The use of ACTR1B as a biomarker for cancer has the potential to improve the accuracy and sensitivity of diagnostic tests and to identify new targets for cancer therapies.

Conclusion

Actinin-associated protein 1B (ACTR1B) is a protein that is involved in a wide range of cellular processes, including cytoskeletal organization, cell signaling pathways, and cell survival. Several studies have identified potential drug targets and biomarkers associated with ACTR1B, making it an attractive candidate for further research and development. Further studies are needed to fully understand the role of ACTR1B in

Protein Name: Actin Related Protein 1B

Functions: Component of a multi-subunit complex involved in microtubule based vesicle motility. It is associated with the centrosome

The "ACTR1B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ACTR1B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets